Table of Contents Author Guidelines Submit a Manuscript
Journal of Thyroid Research
Volume 2017 (2017), Article ID 9807543, 9 pages
https://doi.org/10.1155/2017/9807543
Clinical Study

18F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study

1Radiation Oncology Center, Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy
2Nuclear Medicine Unit, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy
3Medical Physics Department, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy
4Division of Endocrinology, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy
5Radiology Unit, Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy
6Radiation Oncology Unit, Bellaria Hospital, Bologna, Italy
7Radiotherapy Unit, Azienda Ospedaliera Universitaria Integrata, Ospedale Civile Maggiore, Verona, Italy
8Gemelli Advanced Radiation Therapy Center, Fondazione Policlinico Universitario “A. Gemelli”, Catholic University of Sacred Heart, Rome, Italy
9Radiotherapy Unit, Department of Oncology, “Giovanni Paolo II” Foundation, Catholic University of Sacred Heart, Campobasso, Italy
10Medical Physics Unit, “Giovanni Paolo II” Foundation, Catholic University of Sacred Heart, Campobasso, Italy

Correspondence should be addressed to Fabio Monari; moc.liamg@fe.aiparetoidar

Received 20 June 2017; Accepted 18 September 2017; Published 19 October 2017

Academic Editor: Massimo Tonacchera

Copyright © 2017 Eleonora Farina et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. L. Busaidy and M. E. Cabanillas, “Differentiated thyroid cancer: management of patients with radioiodine nonresponsive disease,” Journal of Thyroid Research, vol. 2012, Article ID 618985, 12 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. S. A. Hundahl, I. D. Fleming, A. M. Fremgen, and H. R. Menck, “A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995,” Cancer, vol. 83, no. 12, pp. 2638–2648, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. E. L. Mazzaferri and R. T. Kloos, “Current approaches to primary therapy for papillary and follicular thyroid cancer,” The Journal of Clinical Endocrinology & Metabolism, vol. 86, no. 4, pp. 1447–1463, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. E. K. Lee, Y. J. Lee, Y.-S. Jung et al., “Postoperative simultaneous integrated boost-intensity modulated radiation therapy for patients with locoregionally advanced papillary thyroid carcinoma: Preliminary results of a phase II trial and propensity score analysis,” The Journal of Clinical Endocrinology & Metabolism, vol. 100, no. 3, pp. 1009–1017, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. P. B. Romesser, E. J. Sherman, A. R. Shaha et al., “External beam radiotherapy with or without concurrent chemotherapy in advanced or recurrent non-anaplastic non-medullary thyroid cancer,” Journal of Surgical Oncology, vol. 110, no. 4, pp. 375–382, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Lee and M. Tuttle, “The role of external beam radiotherapy in the treatment of papillary thyroid cancer,” Endocrine-Related Cancer, vol. 13, no. 4, pp. 971–977, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Dennis, J. H. Hay, and D. C. Wilson, “Effect of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-guided Management of Suspected Recurrent Papillary Thyroid Carcinoma: Long-term Follow-up with Tumour Marker Responses,” Clinical Oncology, vol. 24, no. 10, pp. e168–e172, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Bannas, T. Derlin, M. Groth et al., “Can18F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?” Annals of Nuclear Medicine, vol. 26, no. 1, pp. 77–85, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Asa, S. Y. Aksoy, B. Vatankulu et al., “The role of FDG-PET/CT in differentiated thyroid cancer patients with negative iodine-131 whole-body scan and elevated anti-Tg level,” Annals of Nuclear Medicine, vol. 28, no. 10, pp. 970–979, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. P. W. Souza Rosário, S. de Faria, L. Bicalho et al., “Ultrasonographic differentiation between metastatic and benign lymph nodes in patients with papillary thyroid carcinoma,” Journal of Ultrasound in Medicine, vol. 24, no. 10, pp. 1385–1389, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Braga-Basaria and M. D. Ringel, “Clinical review 158: beyond radioiodine: a review of potential new therapeutic approaches for thyroid cancer,” The Journal of Clinical Endocrinology & Metabolism, vol. 88, no. 5, pp. 1947–1960, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Lind and S. Kohlfürst, “Respective Roles of Thyroglobulin, Radioiodine Imaging, and Positron Emission Tomography in the Assessment of Thyroid Cancer,” Seminars in Nuclear Medicine, vol. 36, no. 3, pp. 194–205, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. G. U. Vural, B. E. Akkas, N. Ercakmak, S. Basu, and A. Alavi, “Prognostic significance of FDG PET/CT on the follow-up of patients of differentiated thyroid carcinoma with negative 131I whole-body scan and elevated thyroglobulin levels: Correlation with clinical and histopathologic characteristics and long-term follow-up data,” Clinical Nuclear Medicine, vol. 37, no. 10, pp. 953–959, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Shammas, B. Degirmenci, and J. M. Mountz, “18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer,” Journal of Nuclear Medicine, vol. 48, pp. 221–226, 2007. View at Google Scholar
  15. M. Chao, “Management of differentiated thyroid cancer with rising thyroglobulin and negative diagnostic radioiodine whole body scan,” Clinical Oncology, vol. 22, no. 6, pp. 438–447, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. “Common Toxicity Criteria for Adverse Events (CTCAE) version 4.03. Department of Health and Human Services, National Institute of Health, National Cancer Institute,” https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf.
  17. J. D. Cox, J. Stetz, and T. F. Pajak, “Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC),” International Journal of Radiation Oncology Biology Physics, vol. 31, no. 5, pp. 1341–1346, 1995. View at Publisher · View at Google Scholar · View at Scopus
  18. R. L. Wahl, H. Jacene, Y. Kasamon, and M. A. Lodge, “From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors,” Journal of Nuclear Medicine, vol. 50, no. 1, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. M. E. A. O'Connell, R. P. A'Hern, and C. L. Harmer, “Results of external beam radiotherapy in differentiated thyroid carcinoma: a retrospective study from the Royal Marsden Hospital,” European Journal of Cancer, vol. 30, no. 6, pp. 733–739, 1994. View at Publisher · View at Google Scholar · View at Scopus
  20. K. M. Meadows, R. J. Amdur, C. G. Morris, D. B. Villaret, E. L. Mazzaferri, and W. M. Mendenhall, “External beam radiotherapy for differentiated thyroid cancer,” American Journal of Otolaryngology-Head and Neck Medicine and Surgery, vol. 27, no. 1, pp. 24–28, 2006. View at Publisher · View at Google Scholar
  21. T. H. Kim, K.-W. Chung, Y. J. Lee et al., “The effect of external beam radiotherapy volume on locoregional control in patients with locoregionally advanced or recurrent nonanaplastic thyroid cancer,” Journal of Radiation Oncology, vol. 5, no. 1, article no. 69, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. M. A. Sia, R. W. Tsang, T. Panzarella, and J. D. Brierley, “Differentiated thyroid cancer with extrathyroidal extension: Prognosis and the role of external beam radiotherapy,” Journal of Thyroid Research, vol. 2010, Article ID 183461, 2010. View at Publisher · View at Google Scholar · View at Scopus